| In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer's disease G Watt, T Karl Frontiers in pharmacology 8, 234828, 2017 | 274 | 2017 |
| Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ 40 Levels in 12-Month-Old Male AβPP swe/PS1ΔE9 Transgenic Mice G Watt, K Shang, J Zieba, J Olaya, H Li, B Garner, T Karl Journal of Alzheimer's Disease 74 (3), 937-950, 2020 | 55 | 2020 |
| Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines M Sharman, G Verdile, S Kirubakaran, C Parenti, A Singh, G Watt, T Karl, ... CNS Drugs 33, 2019 | 38 | 2019 |
| Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APPSwe/PS1ΔE9 transgenic female mice M Coles, G Watt, F Kreilaus, T Karl Frontiers in pharmacology 11, 587604, 2020 | 34 | 2020 |
| Novel behavioural characteristics of male human P301S mutant tau transgenic mice–a model for tauopathy G Watt, M Przybyla, V Zak, J van Eersel, A Ittner, LM Ittner, T Karl Neuroscience 431, 166-175, 2020 | 18 | 2020 |
| Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice G Watt, R Chesworth, M Przybyla, A Ittner, B Garner, LM Ittner, T Karl Pharmacology Biochemistry and Behavior 196, 172970, 2020 | 16 | 2020 |
| Cannabinoid Modulation of Object Recognition and Location Memory—A Preclinical Assessment R Chesworth, G Watt, T Karl Handbook of behavioral neuroscience 27, 461-488, 2018 | 8 | 2018 |
| The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice F Kreilaus, R Masanetz, G Watt, M Przybyla, A Ittner, L Ittner, T Karl Behavioural Brain Research 397, 112943, 2021 | 4 | 2021 |
| Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice R Chesworth, HCH Yim, G Watt, E El-Omar, T Karl Progress in Neuro-Psychopharmacology and Biological Psychiatry 133, 111014, 2024 | | 2024 |
| Light phase does not affect operant sucrose self-administration in adult male C57BL/6JAbr mice G Watt, T Karl, R Chesworth Behavioural Brain Research 454, 114650, 2023 | | 2023 |
| Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Mice M Coles, G Watt, F Kreilaus, T Karl Cannabidiol Treatment in Neurotherapeutic Interventions, 2021 | | 2021 |
| Effect of 50 mg/kg CBD on AD-relevant phenotypes of APPxPS1 transgenic mice G Watt, K Shang, J Zieba, J Olaya, H Li, B Garner, T Karl, G Watt, K Shang, ... The therapeutic potential of the phytocannabinoid cannabidiol (CBD) for …, 2020 | | 2020 |
| Effect of 100 mg/kg CBD on AD-relevant phenotypes of APPSwe/PS1∆ E9 double transgenic mice G Watt, J Olaya, B Garner, T Karl The therapeutic potential of the phytocannabinoid cannabidiol (CBD) for …, 2020 | | 2020 |
| Behavioural characterisation of TAU58/2 transgenic males G Watt, M Przybyla, V Zak, J van Eersel, A Ittner, LM Ittner, T Karl, G Watt, ... The therapeutic potential of the phytocannabinoid cannabidiol (CBD) for …, 2020 | | 2020 |
| Effect of 50 mg/kg CBD on AD-relevant phenotypes of TAU58/2 transgenic mice G Watt, R Chesworth, M Przybyla, B Garner, A Ittner, LM Ittner, T Karl, ... The therapeutic potential of the phytocannabinoid cannabidiol (CBD) for …, 2020 | | 2020 |
| The therapeutic potential of the phytocannabinoid cannabidiol (CBD) for Alzheimer’s disease G Watt | | 2020 |
